Upcoming Session
LECTURE 4
Curative therapies for hemoglobin disorders
Saturday, February 27th 2021
9.00 pm (IST)
Prof. Martin H.Steinburg MDProfessor, Hematology and Medical Oncology, Boston University School of Medicine
Fetal Hemoglobin in Sickle Cell Anemia: Bedside➙Bench➙Bedside and Beyond
Saturday, February 20th 20217.00 pm (IST)[Lecture Online]
Prof. Stuart Orkin, M.D
David G. Nathan Distinguished Professor of Pediatrics, Howard Hughes Medical Institute (HHMI) InvestigatorHarvard Medical School, Boston, USATurning on fetal hemoglobin for therapy: mechanism and translation
February 6th, 2021, 7.00 pm (India time) and 8.30 am(Boston time) [Lecture Online]
Prof. Matthew Porteus MD PhD
Professor of Paediatrics, Stanford School of Medicine, California.Genome Editing to Cure Hemoglobinopathies
Saturday, February 13th, 2021 9.00 pm (IST) [Lecture Online]
The sessions would be online and the link to the sessions would be communicated to registered participants
Speakers & Sessions
Prof. Stuart Orkin, M.DDavid G. Nathan Distinguished Professor of Pediatrics, Howard Hughes Medical Institute (HHMI) InvestigatorHarvard Medical School, Boston, USAFebruary 6th, 2021, 7.00 pm (India time) and 8.30 am(Boston time) [Lecture Online]
Prof. Matt Porteus MD PhDProfessor of Paediatrics, Stanford School of Medicine, California.February 13th, 2021, 9.00 pm (India time) and 7.30 am (California time)
Prof. Martin H.Steinburg MDProfessor, Hematology and Medical Oncology, Boston University School of MedicineFebruary 20th, 2021, 7.00 pm (India time) and 8.30 am (Boston time)
Prof. Mark C. Walters, MDJordan Family Director, Blood and Marrow Transplantation, Professor of PediatricsUCSF Benioff Children’s Hospital, OaklandFebruary 27th, 2021, 9.00 pm (India time) and 7.30 am (California time).
Prof. David Williams , MDLeland Fikes Professor of PediatricsHarvard Medical SchoolMarch 6th, 2021, 07.00 PM (India time)
Hemoglobinopathies 2018
The aim of the meeting was to discuss new developments in scientific and clinical advances to counter hemoglobinopathies, including the mechanisms for new therapeutic targets, curative therapies like gene therapy and genome editing approaches. The meeting also enabled close interactions between clinicians and scientists working in the area towards creating collaborative translational efforts in the area of hemoglobinopathies.
Genomics for Precision Medicine in India
Pioneering Genomics in India for over a Decade
GUaRDIAN is a collaborative research programme towards understanding the genetic basis and molecular mechanisms underlying rare genetic disorders. We use the advanced sequencing technologies, extensive bioinformatics and animal models. Our collaborators include a large number of clinicians and scientists.
know more